Lupin hits new high on USFDA nod for anti-inflammatory drug

Lupin hits new high on USFDA nod for anti-inflammatory drug

The US subsidiary received approval from US Food and Drug Administration (USFDA) for anti-inflammatory drug Celecoxib (Celebrex). The company has been selling this drug as an authorised generic. With the current US FDA approval, Lupin's market share …

(Visited 5 times, 1 visits today)
9
Like
Save

Comments

Comments are disabled for this post.